Capitalizing on outperformance of Red Hat, Lowe's.
TheStreet's Jim Cramer says he doesn't like GoDaddy because he doesn't know what's going to get this stock going higher.
Schlumberger’s scale, market leadership and pricing power make it defensible amidst low oil prices.
TheStreet's Jim Cramer says we're seeing a top in biotechs.
Getting out of Walgreens while the getting's good.
Twitter's Periscope live video-streaming app provides a vital platform for growth.
Jim Cramer indicates what to watch for when rival Monsanto reports 2Q results.
In a host of industries, everyone expects Google will either buy key service providers, or launch competing services. But while the FTC stalls Google, other companies could outflank it.
TheStreet's Jim Cramer says he's keeping an eye on Monsanto Wednesday to see if the company can turn the tide when it reports Q2 results before the open.
Healthcare, biotech, the U.S. dollar and oil prices are what investors will want to watch in Q2, says TheStreet's Jim Cramer.